Clinical Trial Update: PREVENTion With Sglt-2 Inhibition of Acute Kidney Injury in Intensive Care [Phase 3]

View source ↗

Summary

Phase 3 trial PREVENTion With SGLT-2 Inhibition of Acute Kidney Injury in Intensive Care was terminated. The update provides limited information beyond the term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• SGLT-2 inhibitor (class)

Snippet

Sponsor: The George Institute | Conditions: Acute Kidney Injury | Phase 3 | Status: TERMINATED